

Prof Angela Tincani
Professor Angela Tincani is a senior consultant (previously director) at the Rheumatology and Clinical Immunology Unit of Aziende Socio Sanitaria Territoriali (ASST)-Spedali Civili and University of Brescia, Italy.
Professor Tincani has been involved in several international committees for education and research in the field of systemic autoimmune diseases. Professor Tincani’s primary clinical and research interests include the use of anti-rheumatic drugs in pregnant and lactating patients and the management of pregnancy in rheumatic disease patients, in addition to evaluating autoantibodies and autoimmune diseases as risk factors for poor gestational outcomes. She served as an expert for several European Alliance of Associations for Rheumatology (EULAR) recommendations, including “Points to consider for use of anti-rheumatic drugs before pregnancy and during pregnancy and lactation”. Together with Professor Andreoli, Professor Tincani is co-principal investigator of the “Italian Registry of Pregnancy in Rheumatic Diseases”.

Navigating the new European S2k guidelines for hidradenitis suppurativa: How will they change your clinical practice?
Unlock the European S2k HS guidelines. Prof. Tzellos and Prof. Bechara share expert insights and implications of the updated guidelines
Accompany Dr Ann-Sophie De Craemer as she discusses management options for a patient with axSpA exhibiting few symptoms.
Work through the challenges in diagnosing suspected axSpA in two patient cases with Dr Michael Nissen and Dr Philipp Julian Bosch.
Join Dr Lykke Midtbøll Ørnbjerg as she explores the value of registry data for informing clinical practice in axSpA.
Watch Dr Floris van Gaalen explore whether early diagnosis of axSpA is possible, drawing on findings from the SPACE cohort.1

Setting up MDT care in HS: Learning from psoriasis
Establishing a multidisciplinary team to alleviate disease burden and optimise patient outcomes, using the principles of value-based healthcare